Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2022-08-24 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
2022年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2022 年半年度报告全文" which translates to "2022 Semi-Annual Report Full Text". It contains detailed financial data, management discussion and analysis, company overview, business segments, financial indicators, and other comprehensive information typical of an interim or quarterly report. The report period is specified as January 1, 2022 to June 30, 2022, confirming it covers a half-year period. The document length is substantial (15,000 characters), and it includes actual financial statements and substantive financial data, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-24 Chinese
半年报监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board regarding the approval of the company's 2022 half-year report and its summary. It confirms the meeting details, voting results, and compliance with legal and regulatory requirements. The document does not contain the actual half-year financial report or substantive financial data but rather announces the approval and availability of the report on external websites. The document length is short (774 characters), and it states that the half-year report is published elsewhere for investors to review. Therefore, this is an announcement related to the report, not the report itself. According to the rules, such announcements are classified as Regulatory Filings (RNS) rather than Interim/Quarterly Reports (IR).
2022-08-24 Chinese
半年报董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's third board meeting, specifically approving the 2022 half-year report and its summary. It states that the half-year report has been reviewed and is available on official websites. The document itself does not contain the full half-year financial report or detailed financial data but rather announces the board's approval and provides references to where the report can be accessed. The document length is short (842 characters), and it serves as a meeting resolution announcement rather than the report itself. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not contain full financial reports.
2022-08-24 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 85% confidence The document is a summary table detailing non-operating fund occupation and other related party fund transactions for the half-year period of 2022. It includes financial figures such as balances, interest, and repayment amounts, and identifies relationships between the company and related parties. The document is relatively short (1378 characters) and appears to be a specific financial disclosure related to related party transactions rather than a full interim or annual report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is more of a regulatory disclosure or supplementary financial information. Given the nature and length, and that it does not fit neatly into other categories, the best classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory disclosures that do not fit other categories.
2022-08-24 Chinese
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 90% confidence The document is an independent director's opinion related to the company's third board meeting, specifically addressing related party fund occupation and external guarantees for the first half of 2022. It references regulatory guidelines and provides an independent opinion rather than full financial statements or detailed audit results. The document length is short (516 characters), and it is a formal opinion rather than a full audit report or annual/interim report. This fits best under Audit Report / Information (AR) as it relates to audit-like independent opinions on specific financial matters, but is not a full annual report or interim report. Therefore, the classification is AR with high confidence. H1 2022
2022-08-24 Chinese
2022年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "二〇二二年上半年财务报告 (未经审计)" which translates to "2022 Half-Year Financial Report (Unaudited)". It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2022. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2022
2022-08-24 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.